First Time Loading...
H

High Tech Pharm Co Ltd
KOSDAQ:106190

Watchlist Manager
High Tech Pharm Co Ltd
KOSDAQ:106190
Watchlist
Price: 12 150 KRW -0.41% Market Closed
Updated: May 8, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
High Tech Pharm Co Ltd

Wall Street analysts forecast High Tech Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for High Tech Pharm Co Ltd is 26 000 KRW .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
26 000 KRW
114% Upside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
26 000 KRW
114% Upside
Highest
Price Target
Not Available
High Tech Pharm Co Ltd Competitors:
Price Targets
PBH
Prestige Consumer Healthcare Inc
10% Upside
HCM
HUTCHMED (China) Ltd
23% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
3% Upside
CPH
Cipher Pharmaceuticals Inc
28% Upside
PBH
Prestige Consumer Healthcare Inc
10% Upside
HCM
HUTCHMED (China) Ltd
23% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
3% Upside
CPH
Cipher Pharmaceuticals Inc
28% Upside
A
ABBOTINDIA
Abbott India Ltd
13% Upside
XERS
Xeris Biopharma Holdings Inc
158% Upside
H
300086
Honz Pharmaceutical Co Ltd
374% Upside
T
600867
Tonghua Dongbao Pharmaceutical Co Ltd
38% Upside

Revenue
Forecast

Revenue Estimate
High Tech Pharm Co Ltd

Revenue forecast
is not available for
High Tech Pharm Co Ltd

Operating Income
Forecast

Operating Income Estimate
High Tech Pharm Co Ltd

Operating Income forecast
is not available for
High Tech Pharm Co Ltd

Net Income
Forecast

Net Income Estimate
High Tech Pharm Co Ltd

Net Income forecast
is not available for
High Tech Pharm Co Ltd

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is High Tech Pharm Co Ltd's stock price target?
Price Target
26 000 KRW

According to Wall Street analysts, the average 1-year price target for High Tech Pharm Co Ltd is 26 000 KRW .

ALPHA SPREAD
Join more than 135,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.